TATYANA RADULOVIC: Open Payments
NPI 1871974964 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 21 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $150 · 2025 $464
Food & beverage: $447Education: $17
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 5 | $147 |
| Insmed, Inc. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Amgen Inc. | 2 | $34 |
| United Therapeutics Corporation | 1 | $25 |
| Pulmonx Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Ohtuvayre, Arikayce, GLASSIA, FASENRA, TEZSPIRE, Tyvaso, OFEV, JASCAYD.
Industry payments across WI — which companies pay providers there.
